Autoantibody detection remains essential in diagnosing autoimmune liver diseases (AILD), particularly autoimmune hepatitis (AIH), in which smooth muscle antibodies (SMA) targeting filamentous actin (F-actin) are commonly observed. Here, SMN1 is linked to angioimmunoblastic T-cell lymphoma.